胺碘酮治疗预激综合征合并快速心律失常35例

Amiodarone in treatment of Wolff-ParkinsonWhite syndrome combined with rapid arrhythmia:35 cases

目的:探讨胺碘酮对预激综合征(WPW)合并阵发性室上性心动过速的临床疗效.方法:选择我院35例WPW合并阵发性室上性心动过速患者作为观察对象.所有患者入院后均接受抗心律失常治疗,待到恢复窦性心律后,再给予胺碘酮。最终评价患者临床疗效.结果:治疗后,显效16例,有效17例,无效2例,总有效率高达94.29%(33/35).此外,治疗后患者心率显著降低(P<0.01).结论:应用胺碘酮治疗WPW合并阵发性室上性心动过速疗效显著,值得临床推广应用.

AIM： To investigate the clinical effect of amiodarone on Wolff-Parkinson-White syndrome （WPW） combined with par- oxysmal supraventricular tachycardia. METHODS： 35 cases with WPW combined with paroxysmal supraventricular tachycardia were observed. All 35 patients admitted to our hospital were treated with anti-arrhythmic therapy, and amiodarone was prescribed once sinus rhythm was restored. Clinical efficacy was evaluated. RE- SULTS： Upon treatment, 16 cases were significantly improved, 17 cases were effective and no effect was observed in 2 cases, with total effective rate being 94. 29% （33/35）. In addition, heart rate was significantly decreased （ P 〈 0.01 ）. CONCLU- SION ： The application of amiodarone in treatment of WPW com- bined with paroxysmal ventricular tachycardia has significant cura- tive effect and is worthy of clinical popularization and application.